BI-4394
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


BI-4394
Description :
BI-4394 (MMP13-IN-3), a chemical probe, is a potent, selective, and orally active MMP-13 inhibitor (IC50=1 nM[1]) for the potential treatment of osteoarthritis[2]. BI-4394 is >1000 selective over other MMPs[1].Product Name Alternative :
MMP13-IN-3UNSPSC :
12352005Target :
MMPType :
Reference compoundRelated Pathways :
Metabolic Enzyme/ProteaseApplications :
COVID-19-immunoregulationField of Research :
Inflammation/ImmunologyAssay Protocol :
https://www.medchemexpress.com/bi-4394.htmlPurity :
99.09Solubility :
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)Smiles :
O=C(C(N1)=CC2=C1C=CC(C3=CC(C(NCC4=CC=C(C(O)=O)C=C4)=O)=NN3C)=C2)OCCMolecular Formula :
C24H22N4O5Molecular Weight :
446.46References & Citations :
[1]Taylor SJ, et al. Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13. J Med Chem. 2011 Dec 8;54 (23) :8174-87.|[2]Ruminski PG, et al. Discovery of N- (4-Fluoro-3-methoxybenzyl) -6- (2- (((2S,5R) -5- (hydroxymethyl) -1,4-dioxan-2-yl) methyl) -2H-tetrazol-5-yl) -2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis. J Med Chem. 2016 Jan 14;59 (1) :313-27.Shipping Conditions :
Room TemperatureStorage Conditions :
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category :
Reference compound1Clinical Information :
No Development ReportedIsoform :
MMP-10; MMP-13; MMP-14; MMP-2; MMP-9CAS Number :
[1222173-37-6]

